Cocrystal Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cocrystal Pharma generated cash of -$14,666,000, which is more than the previous year. Cash used in financing activities reached the amount of $3,993,000 last year. Net change in cash is therefore -$10,791,000.
Cash Flow
| 2014 | -6.00M | 6.07M | 2.86K |
|---|---|---|---|
| 2015 | -10.31M | -262K | 15.88K |
| 2016 | -14.65M | 3K | 9.01K |
| 2017 | -6.90M | -40K | 4.08M |
| 2018 | -8.29M | 1.37M | 8.89M |
| 2019 | -1.56M | -145K | 6.42M |
| 2020 | -9.83M | -240K | 35.66M |
| 2021 | -12.71M | -52K | 38.46M |
| 2022 | -21.43M | -74K | -27K |
| 2023 | -14.66M | -118K | 3.99M |
COCP Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 37.21M | 58.75M | 33.06M | 7.46M | 2.75M | 777K | 3.64M | 9.27M | 3.97M | 1.03M |
Operating activities | ||||||||||
Net income | -17.98M | -38.83M | -14.18M | -9.64M | -48.16M | -49.04M | -613K | -74.87M | -50.12M | -99K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | -1.38M | 388K | 190K | 157K | 98K | 50K | 101K | 201K | 192K | 199K |
Stock-based compensation expense | 801K | 855K | 724K | 662K | 351K | 0 | 614K | 548K | 2.93M | 38K |
| Deferred income tax benefit | 801K | 855K | 724K | 662K | 351K | 0 | 614K | 548K | 2.93M | 38K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -716K | 556K | 88K | -644K | 0 | 20K | 11K | 0 | 0 |
Inventories | 0 | 716K | -217K | 919K | -919K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.04M | -321K | 217K | -919K | 919K | 0 | 281K | -2.02M | 0 | 0 |
Cash generated by operating activities | -14.66M | -21.43M | -12.71M | -9.83M | -1.56M | -8.29M | -6.90M | -14.65M | -10.31M | -6.00M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.62M |
Investments In Property Plant And Equipment | -118K | -74K | -52K | -240K | -145K | -28K | -40K | -51K | -339K | -5K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 783K |
Cash generated by investing activities | -118K | -74K | -52K | -240K | -145K | 1.37M | -40K | 3K | -262K | 6.07M |
Financing activities | ||||||||||
Common Stock Issued | 4M | 0 | 38.50M | 35.78M | 6.63M | 7.68M | 3M | 0 | 15.86M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -7K | -27K | -39K | -121K | -214K | -19K | 1M | 0 | 0 | 0 |
Cash used in financing activities | 3.99M | -27K | 38.46M | 35.66M | 6.42M | 8.89M | 4.08M | 9.01K | 15.88K | 2.86K |
Net Change In Cash | -10.79M | -21.53M | 25.69M | 25.59M | 4.71M | 1.97M | -2.86M | -5.63M | 5.30M | 2.93M |
Cash at end of period | 26.42M | 37.21M | 58.75M | 33.06M | 7.46M | 2.75M | 777K | 3.64M | 9.27M | 3.97M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |